[Form 3] Evoke Pharma Inc Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Evoke Pharma (EVOK): Roger Klein filed a Form 3, the initial statement of beneficial ownership, with a date of event of 11/04/2025. He is identified as a Director.

The filing lists Common Stock 34,000 held indirectly by his Roth IRA and Common Stock 129,000 held indirectly by the Krieger Charitable Trust, for which he is sole trustee. The filing notes a disclaimer of beneficial ownership except to the extent of his pecuniary interest.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Klein Roger M.

(Last) (First) (Middle)

C/O CHOATE, HALL & STEWART

TWO INTERNATIONAL PLACE

(Street)

BOSTON MA 02110

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/04/2025

3. Issuer Name and Ticker or Trading Symbol
Evoke Pharma Inc [ EVOK ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	34,000	I(1)	By IRA
Common Stock	129,000	I(2)	By Krieger Charitable Trust

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents securities of the Issuer owned directly by Mr. Klein's Roth Investment Retirement Account ("IRA").

2. Represents securities of the Issuer owned directly by Krieger Charitable Trust (the "Trust"). Mr. Klein, as sole trustee of the Trust, may be deemed to beneficially own the securities of the Issuer owned directly by the Trust. Mr. Klein disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that Mr. Klein is a beneficial owner of the securities reported herein.

	/s/ Roger Klein	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did EVOK disclose in this Form 3 filing?

A Director, Roger Klein, filed an initial statement of beneficial ownership listing indirect holdings in Common Stock.

How many EVOK shares are reported via Roger Klein’s IRA?

The filing reports 34,000 shares of Common Stock held indirectly by his Roth IRA.

How many EVOK shares are reported via the Krieger Charitable Trust?

The filing reports 129,000 shares of Common Stock held indirectly by the Krieger Charitable Trust.

What is Roger Klein’s relationship to Evoke Pharma (EVOK)?

He is listed as a Director of Evoke Pharma Inc.

What is the date of event for this Form 3?

The date of event requiring the statement is 11/04/2025.

Does the filing include a beneficial ownership disclaimer?

Yes. It states Mr. Klein disclaims beneficial ownership except to the extent of his pecuniary interest.

Who signed the Form 3 and when?

It was signed /s/ Roger Klein on 11/06/2025.